2025-07-03
On June 25, 2025, the team led by Professor Wang Huiying and Dr. Jin Bo from Shenzhen Hospital of Beijing University of Chinese Medicine collaborated with Shandong Yinfeng Life Science Research Institute to develop the "ovarian dual activation" technology. Through this technology, patients with POI (primary ovarian insufficiency) underwent intra - operative freeze - thaw activation of ovarian tissue. After intra - operative transplantation, a baby was born, and both the mother and the baby are healthy and safe.
2025-06-27
Recently, the team led by Alison Marsden from Stanford University in the United States published a significant breakthrough in the journal Science. They successfully developed a computational model that can rapidly design the vascular network for 3D - printed organs. This technology is expected to greatly reduce the manufacturing time of artificial organs and offer new solutions to the problem of organ transplantation shortage.
2025-06-27
In June 2025, the team led by Liu Jia from Harvard University published a groundbreaking study in the journal *Nature*. They developed an ultra - flexible brain - computer interface device, which for the first time achieved non - invasive, high - resolution recording of neural electrical activities during the development of the vertebrate embryonic brain. This opens up a new way to understand the brain construction mechanism and the origin of neurodevelopmental diseases.
2025-06-19
Milestone! A Chinese Scientist Team Unveils a New Approach to Anti - aging and Lifespan Extension
Recently, the research group led by Liu Guanghui from the Institute of Zoology, Chinese Academy of Sciences, in collaboration with the teams of Wang Si from Xuanwu Hospital, Capital Medical University, and Qu Jing from the Institute of Zoology, Chinese Academy of Sciences, published a significant research paper in the journal Cell. This study delved deep into the aging regulatory mechanism and used synthetic biology methods to reprogram the longevity gene pathway. As a result, engineered human anti - aging mesenchymal progenitor cells (SRC) with triple resistance to aging, stress, and malignant transformation were successfully constructed.
2025-06-19
Recently, the world's top - tier academic journal Nature featured a major research achievement by Chinese scientists on its front - page headlines. For the first time, a heart containing human cells was cultivated in a pig embryo, and this heart could beat autonomously and survived for 21 days. This groundbreaking progress offers a brand - new solution to the global shortage of organ transplants and marks a new stage in the development of xenogeneic organ cultivation technology.
2025-06-13
A Blockbuster in Science! U.S. Discovers a Switch to Reverse Diabetes, Offering Hope for Treatment
A groundbreaking study published in the international top - tier journal Science in February this year may bring revolutionary hope to hundreds of millions of type 2 diabetes patients worldwide. The team of scientists from the University of Michigan in the United States not only uncovered a core secret of diabetes onset but, even more excitingly, they successfully reversed the damage, which may completely transform the diabetes treatment model.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155515
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
